Binding areas of urokinase-type plasminogen activator-plasminogen activator inhibitor-1 complex for endocytosis receptors of the low-density lipoprotein receptor family, determined by site-directed mutagenesis.
about
Specificity of binding of the low density lipoprotein receptor-related protein to different conformational states of the clade E serpins plasminogen activator inhibitor-1 and proteinase nexin-1Dependence on endocytic receptor binding via a minimal binding motif underlies the differential prognostic profiles of SerpinE1 and SerpinB2 in cancer.Serum-stable RNA aptamers to urokinase-type plasminogen activator blocking receptor binding.Protein-binding RNA aptamers affect molecular interactions distantly from their binding sitesSerpin-Enzyme Receptors LDL Receptor-Related Protein 1.A proximal pair of positive charges provides the dominant ligand-binding contribution to complement-like domains from the LRP (low-density lipoprotein receptor-related protein)The High Affinity Binding Site on Plasminogen Activator Inhibitor-1 (PAI-1) for the Low Density Lipoprotein Receptor-related Protein (LRP1) Is Composed of Four Basic Residues.Urokinase links plasminogen activation and cell adhesion by cleavage of the RGD motif in vitronectin.Inhibitory serpins. New insights into their folding, polymerization, regulation and clearance.A structural basis for differential cell signalling by PAI-1 and PAI-2 in breast cancer cells.New horizons for lipoprotein receptors: communication by β-propellers.The low-density lipoprotein receptor-related protein 1 (LRP1) mediates the endocytosis of the cellular prion protein.
P2860
Q24650291-ED5D4C4F-2FB5-434D-98CA-89E24EA8C64DQ30502082-EFFFB523-6B32-418F-995A-42B946459D24Q34370103-6072B775-665D-4ABA-BF1B-9550D66D6383Q35203415-0319A0F3-AE95-45CC-879C-2721C5F5AFEAQ35295478-24BB7C5A-35AA-4221-9794-A7D664595CC6Q35832624-89F1597C-B1F6-4DCA-BD5E-C0120F24345FQ36442395-7B588C75-3D9E-437F-81E4-C6AE86DB228AQ38770258-803A814C-3D4F-4C2F-AF01-EA6F4E3DADA3Q38912052-B40864B8-7F94-4377-804F-47986BA99ADCQ41823150-8FF378A1-A406-4581-BD3F-2A87A096E485Q42105665-2D4B8CB4-233F-45BB-8B04-B57ABE2F7849Q42976032-57077E4F-B7F7-4AB7-A56F-3226F7EAE097
P2860
Binding areas of urokinase-type plasminogen activator-plasminogen activator inhibitor-1 complex for endocytosis receptors of the low-density lipoprotein receptor family, determined by site-directed mutagenesis.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Binding areas of urokinase-typ ...... by site-directed mutagenesis.
@en
Binding areas of urokinase-typ ...... by site-directed mutagenesis.
@nl
type
label
Binding areas of urokinase-typ ...... by site-directed mutagenesis.
@en
Binding areas of urokinase-typ ...... by site-directed mutagenesis.
@nl
prefLabel
Binding areas of urokinase-typ ...... by site-directed mutagenesis.
@en
Binding areas of urokinase-typ ...... by site-directed mutagenesis.
@nl
P2093
P2860
P1433
P1476
Binding areas of urokinase-typ ...... by site-directed mutagenesis.
@en
P2093
Anni Christensen
Helle H Petersen
Jakob V Larsen
Jan K Jensen
Jørgen Gliemann
Katrine E Pedersen
Peter A Andreasen
Rikke Egelund
Sune Skeldal
P2860
P304
P356
10.1111/J.1742-4658.2006.05511.X
P407
P577
2006-10-17T00:00:00Z